Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer - Drug Trials For Money - Paid Clinical Trials

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
Conditions:   Breast Cancer;   HER2-negative Breast Cancer;   Node-negative Breast Cancer;   Breast Carcinoma
Interventions:   Drug: Anastrozole 1mg;   Drug: Letrozole 2.5mg;   Drug: Exemestane 25 mg;   Drug: Tamoxifen
Sponsor:   Emily Marcinkowski
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 10, 2021 / by / in
Comments